Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Adma Biologics
(NQ:
ADMA
)
2.090
USD
-0.140 (-6.28%)
Official Closing Price
Updated: 7:43 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Adma Biologics
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
BRIEF-ADMA Biologics announces proposed public offering of common stock
April 27, 2016
* Adma Biologics announces proposed public offering of common stock Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Tags
companyNews
From
Reuters: Company News
ADMA Biologics Announces Proposed Public Offering of Common Stock
April 27, 2016
ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
BRIEF-ADMA Biologics announces data on RI-002
April 12, 2016
* Announces data on RI-002 to be presented at the Clinical Immunology Society 2016 annual meeting
Tags
companyNews
From
Reuters: Company News
ADMA Biologics Announces Data on RI-002 to be Presented at the Clinical Immunology Society 2016 Annual Meeting
April 12, 2016
ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
BRIEF-Adma biologics reports FY loss per share of $1.73
March 23, 2016
* Adma biologics reports year end 2015 financial results, accomplishments and upcoming milestones
Tags
companyNews
From
Reuters: Company News
ADMA Biologics Reports Year End 2015 Financial Results, Accomplishments and Upcoming Milestones
March 23, 2016
ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update
March 09, 2016
Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China.
Tags
Healthcare
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
ADMA Biologics Announces Data Presented at 2016 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI)
March 06, 2016
Abstract titled: “A High Titer Anti-RSV Polyclonal Antibody (RI-002) Prevents Infection with Palivizumab Resistant RSV in Cotton Rats and Achieves Greater Neutralizing Anti-RSV Activity as Compared to...
From
GlobeNewswire News Releases
ADMA Biologics to Present at Cowen and Company 36th Annual Health Care Conference
March 01, 2016
ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
Biggest Movers in Manufacturing Stocks Now – AST KRO ADMA EYEG
February 29, 2016
Tags
NYSE:TPUB
NASDAQ:PRTA
NASDAQ:OASM
From
InvestorPlace
ADMA Biologics Recognized as One of New Jersey’s “Best Places to Work 2016”
February 23, 2016
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
14 Biotechnology Stocks to Sell Now
February 21, 2016
Tags
Stocks to Sell
NASDAQ:VNDA
NASDAQ:EPZM
From
InvestorPlace
The 2016 Small-Cap Biotech Watchlist Debuts At The Biotech Showcase
January 27, 2016
This may prove a challenging year for small-cap biotechs, but the five analysts who selected companies for inclusion on The Life Sciences Report's 2016 Small-Cap Biotech Watchlist believe these...
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
Blogs - TalkMarkets
16 Biotechnology Stocks to Sell Now
December 20, 2015
Tags
NASDAQ:CERU
NASDAQ:TGTX
NASDAQ:CGIX
From
InvestorPlace
ADMA Biologics Expands Commercial Operations Team in Preparation for Commercial Launch of RI-002 in Second Half of 2016
December 08, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), announced today the expansion of its commercial operations team, appointing Alan Erck as the Company’s Vice President, Sales and National Accounts. ADMA Biologics is...
From
GlobeNewswire News Releases
ADMA Biologics to Present at the Oppenheimer 26th Annual Healthcare Conference
December 03, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
ADMA Biologics Reports Third Quarter 2015 Results
November 10, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
ADMA Biologics Announces Data to be Presented at the International Primary Immunodeficiencies Congress in Budapest Hungary
November 02, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
Biggest Movers in Manufacturing Stocks Now – GBX ADMA ANAC AVID
November 01, 2015
Tags
NYSE:TROX
NASDAQ:ITCI
NASDAQ:ADMP
From
InvestorPlace
Hottest Manufacturing Stocks Now – GIG FIT OFLX AGRX
October 30, 2015
Tags
NASDAQ:OCUL
AMEX:GIG
NYSE:GBX
From
InvestorPlace
Hottest Manufacturing Stocks Now – JAGX ANAC RLYP ACW
October 28, 2015
Tags
NASDAQ:ADMA
NYSE:ACW
NYSE:HUN
From
InvestorPlace
BRIEF-Biotest continues cooperation with ADMA Biologics for RSV Hyperimmunoglobulin RI-002
September 30, 2015
* Continues cooperation with ADMA Biologics, Inc. for RSV Hyperimmunoglobulin RI-002
Tags
companyNews
From
Reuters: Company News
ADMA Biologics Receives Milestone Payment From Biotest AG for RI-002 BLA Submission to FDA
September 30, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
ADMA Biologics Recognized as One of the 50 Fastest Growing Companies in New Jersey
September 28, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
ADMA Biologics to Present at the Ladenburg Thalmann 2015 Healthcare Conference
September 22, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of...
From
GlobeNewswire News Releases
FDA Accepts ADMA Biologics License Application for RI-002
September 21, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics, announced that the U.S. Food and...
From
GlobeNewswire News Releases
ADMA Biologics Receives FDA Approval for Second Plasma Collection Center
September 17, 2015
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics, announced that the Company's...
From
GlobeNewswire News Releases
ADMA Biologics to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
September 02, 2015
From
GlobeNewswire News Releases
ADMA Biologics Receives Patent Issuance Pertaining to the Treatment of Immunodeficiency
August 31, 2015
Patent Coverage for RI-002 Immune Globulin (IG) in Immune Compromised PIDD Patients
From
GlobeNewswire News Releases
ADMA Biologics Reports Second Quarter 2015 Results
August 11, 2015
Provides Corporate Update and Anticipated Upcoming Milestones
From
GlobeNewswire News Releases
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.